Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Pugh

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Cancer|November 19, 2016
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trialLynne I Wagner, Stephanie L Pugh, William Small, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 26, 2016
Xerostomia health-related quality of life: NRG oncology RTOG 0537Gwen Wyatt, Stephanie L Pugh, Raimond K W Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 StudyRaimond K W Wong, Snehal Deshmukh, Gwen Wyatt, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Cancer|November 19, 2016
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trialLynne I Wagner, Stephanie L Pugh, William Small, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 26, 2016
Xerostomia health-related quality of life: NRG oncology RTOG 0537Gwen Wyatt, Stephanie L Pugh, Raimond K W Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 StudyRaimond K W Wong, Snehal Deshmukh, Gwen Wyatt, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
Pageof 11